Skip to content

Evaluation of the therapeutic effects of different traditional Chinese medicine treatment methods on benign thyroid nodules

Evaluation of the therapeutic effects of different traditional Chinese medicine treatment methods on benign thyroid nodules

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000751
Enrollment
Unknown
Registered
2025-04-15
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid nodule

Interventions

Experimental group one (external treatment group):Acupuncture and moxibustion program+external application of traditional Chinese medicine+self acupoint manipulation
Experimental Group 2 (Comprehensive Group):Neixiao scrofula pill+acupuncture and moxibustion+external application of traditional Chinese medicine+self acupoint manipulation
Control group (internal treatment group):Neixiao scrofula pill

Sponsors

Medical Ethics Committee of Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) According to the "Ultrasound Diagnosis Specification for Thyroid Nodules" the ultrasound examination confirmed the diagnosis of benign thyroid nodules. (2) Meets the diagnostic criteria for gallbladder disease According to the fourth edition of Traditional Chinese Medicine Internal Medicine benign thyroid nodules should be classified as "gallbladder disease". The diagnostic points are as follows: 1) In the early stage there are often no obvious accompanying symptoms and different clinical manifestations can be seen when the pathogenesis changes. 2) The main manifestation is local symptoms in the neck including lumps and swelling in the front of the neck a feeling of tightness or pain in the neck and a feeling of obstruction in the throat; At the beginning of the clumping it is the size of a cherry or a finger and generally grows slowly with varying sizes. The larger one can be like a bag or pouch soft and smooth to the touch. Over time the clumping becomes harder and fixed and nodules can be felt. (3) Meets the diagnostic criteria for Qi stagnation and phlegm obstruction syndrome Main symptoms: Neck or palpable nodules soft texture occasional feeling of obstruction in the throat irritable or depressed mood good at calming down; Secondary symptoms: often accompanied by swelling of submandibular lymph nodes pain in the ribs dizziness and vertigo and breast swelling and pain in women; Tongue veins: The tongue is dark red in texture covered with yellow and greasy fur and the veins are stringy or smooth. (4) Through the investigation and evaluation of clinical trials patients who are willing to receive combined traditional Chinese and Western medicine treatment (including acupuncture treatment) agree and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Thyroid ultrasound suggests a malignant tendency with high specificity such as microcalcification irregular edges a longitudinal-totransverse ratio greater than 1 or a grading level greater than 3; clinical examination laboratory tests and fine-needle aspiration cytology suggest that thyroidules may undergo malignant transformation; (2) Clinical examination laboratory testing fine needle aspiration cytology and other examinations suggest the possibility of malignant transformation in thyroid nodules; (3) Those who have a history of treating other thyroid diseases and have taken thyroid hormones during the treatment process; (4) Combining hematopoietic system diseases and autoimmune diseases; (5) Patients with severe complications such as heart liver and kidney; (6) Pregnant or lactating women; (7) Psychiatric patients; (8) Those who experience fear and voluntarily withdraw during the acupuncture process.

Design outcomes

Primary

MeasureTime frame
Integral evaluation of traditional Chinese medicine syndrome;CDFI;

Secondary

MeasureTime frame
the MOS item short from health survey(SF-36);Karnofsky Performance Status Score;TCM symptom and curative effect standard;

Countries

China

Contacts

Public ContactJing Deng

Medical Ethics Committee of Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital

9580456@qq.com13668132285

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026